{"DataElement":{"publicId":"7153857","version":"1","preferredName":"Metastatic Diagnosis Child-Pugh Classification Category","preferredDefinition":"The rating assigned based on a standardized scale to describe the severity of liver cirrhosis.  It is used to determine the prognosis of metastatic disease and required strength of treatment.","longName":"7115535v1.0:7114290v1.0","context":"OCCPR","contextVersion":"1","DataElementConcept":{"publicId":"7115535","version":"1","preferredName":"Metastatic Diagnosis Child-Pugh Classification","preferredDefinition":"Any diagnosis indicating the presence of metastatic disease._A standardized rating scale used to assess the severity of liver cirrhosis and determine the prognosis, the required strength of treatment, and the necessity of liver transplantation. This instrument uses the following clinical and lab criteria: encephalopathy grade, ascites, bilirubin, albumin, and prothrombin index.","longName":"6841515v1.0:7115533v1.0","context":"OCCPR","contextVersion":"1","ObjectClass":{"publicId":"6841515","version":"1","preferredName":"Metastatic Diagnosis","preferredDefinition":"Any diagnosis indicating the presence of metastatic disease.","longName":"C162221","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Metastatic Diagnosis","conceptCode":"C162221","definition":"Any diagnosis indicating the presence of metastatic disease.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8EFAFAB2-E712-5A45-E053-F662850A0775","latestVersionIndicator":"Yes","beginDate":"2019-07-31","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-07-31","modifiedBy":"ONEDATA","dateModified":"2019-07-31","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"7115533","version":"1","preferredName":"Child-Pugh Clinical Classification","preferredDefinition":"A standardized rating scale used to assess the severity of liver cirrhosis and determine the prognosis, the required strength of treatment, and the necessity of liver transplantation. This instrument uses the following clinical and lab criteria: encephalopathy grade, ascites, bilirubin, albumin, and prothrombin index.","longName":"C121007","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Child-Pugh Clinical Classification","conceptCode":"C121007","definition":"A standardized rating scale used to assess the severity of liver cirrhosis and determine the prognosis, the required strength of treatment, and the necessity of liver transplantation. This instrument uses the following clinical and lab criteria: encephalopathy grade, ascites, bilirubin, albumin, and prothrombin index.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"9AB6B2D9-0B43-224C-E053-F662850A1089","latestVersionIndicator":"Yes","beginDate":"2019-12-27","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-12-27","modifiedBy":"ONEDATA","dateModified":"2019-12-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008556","version":"1","preferredName":"Assessment Results","preferredDefinition":"the results of evaluations of the patient and the patient's disease.","longName":"ASSESS_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2D08DE9-38BB-7208-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CPTAC: Clinical Proteomic Tumor Analysis Consortium","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"9AB6B2D9-0B54-224C-E053-F662850A1089","latestVersionIndicator":"Yes","beginDate":"2019-12-27","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-12-27","modifiedBy":"KNABLEJ","dateModified":"2020-02-14","changeDescription":"2/14/20 jk Released per CPTAC SME (Linda) review and approval. 12/27/19 jk created for CPTAC LIHC baseline CRF.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"7114290","version":"1","preferredName":"Child-Pugh Classification Category","preferredDefinition":"A standardized rating scale used to assess the severity of liver cirrhosis and determine the prognosis, the required strength of treatment, and the necessity of liver transplantation. This instrument uses the following clinical and lab criteria: encephalopathy grade, ascites, bilirubin, albumin, and prothrombin index._A grouping of items based on some commonality or by user defined characteristics.","longName":"7114290v1.0","context":"OCCPR","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"50","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Grade A (5-6 points) Well Compensated Disease","valueDescription":"Child-Pugh Class A","ValueMeaning":{"publicId":"2931789","version":"1","preferredName":"Child-Pugh Class A","longName":"2931789","preferredDefinition":"Child-Pugh score indicating one-year survival of 100% in patients with chronic liver disease and cirrhosis.  This score is determined by the study of the following five factors: bilirubin, albumin, international normalized ratio, presence and degree of ascites, and presence and degree of encephalopathy.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Child-Pugh Class A","conceptCode":"C113691","definition":"Child-Pugh score indicating one-year survival of 100% in patients with chronic liver disease and cirrhosis.  This score is determined by the study of the following five factors: bilirubin, albumin, international normalized ratio, presence and degree of ascites, and presence and degree of encephalopathy.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"70947BE2-8C4B-FDFA-E040-BB89AD433B54","latestVersionIndicator":"Yes","beginDate":"2009-08-07","endDate":null,"createdBy":"ALAIS","dateCreated":"2009-08-07","modifiedBy":"COOPERM","dateModified":"2018-08-22","changeDescription":"Concept annotation added for UPitt/TCGA.  Ylu, 02/26/2015.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9D363884-960D-60FA-E053-F662850A0649","beginDate":"2019-12-27","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2020-01-28","modifiedBy":"ONEDATA","dateModified":"2020-01-28","deletedIndicator":"No"},{"value":"Grade B (7-9 points) Significant Functional Compromise","valueDescription":"Child-Pugh Class B","ValueMeaning":{"publicId":"2931788","version":"1","preferredName":"Child-Pugh Class B","longName":"2931788","preferredDefinition":"Child-Pugh score indicating one-year survival of 80% in patients with chronic liver disease and cirrhosis.  This score is determined by the study of the following five factors: bilirubin, albumin, international normalized ratio, presence and degree of ascites, and presence and degree of encephalopathy.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Child-Pugh Class B","conceptCode":"C113692","definition":"Child-Pugh score indicating one-year survival of 80% in patients with chronic liver disease and cirrhosis.  This score is determined by the study of the following five factors: bilirubin, albumin, international normalized ratio, presence and degree of ascites, and presence and degree of encephalopathy.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"70947BE2-8C28-FDFA-E040-BB89AD433B54","latestVersionIndicator":"Yes","beginDate":"2009-08-07","endDate":null,"createdBy":"ALAIS","dateCreated":"2009-08-07","modifiedBy":"COOPERM","dateModified":"2018-08-22","changeDescription":"Concept annotation added for UPitt/TCGA.  Ylu, 02/26/2015.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9D363884-9621-60FA-E053-F662850A0649","beginDate":"2019-12-27","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2020-01-28","modifiedBy":"ONEDATA","dateModified":"2020-01-28","deletedIndicator":"No"},{"value":"Unknown: Could not be determined or unsure.","valueDescription":"Indeterminate or Unknown","ValueMeaning":{"publicId":"6841632","version":"1","preferredName":"Indeterminate or Unknown","longName":"6841632","preferredDefinition":"An indication that something is indeterminate or unknown.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Indeterminate or Unknown","conceptCode":"C157157","definition":"An indication that something is indeterminate or unknown.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8EFB6B26-0C86-5A31-E053-F662850A5C7D","latestVersionIndicator":"Yes","beginDate":"2019-07-31","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-07-31","modifiedBy":"ONEDATA","dateModified":"2019-07-31","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9AB26B74-F099-7194-E053-F662850A4802","beginDate":"2019-12-27","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-12-27","modifiedBy":"ONEDATA","dateModified":"2019-12-27","deletedIndicator":"No"},{"value":"Grade C (10-15 points) Decompensated Disease","valueDescription":"Child-Pugh Class C","ValueMeaning":{"publicId":"2931787","version":"1","preferredName":"Child-Pugh Class C","longName":"2931787","preferredDefinition":"Child-Pugh score indicating one-year survival of 45% in patients with chronic liver disease and cirrhosis.  This score is determined by the study of the following five factors: bilirubin, albumin, international normalized ratio, presence and degree of ascites, and presence and degree of encephalopathy.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Child-Pugh Class C","conceptCode":"C113694","definition":"Child-Pugh score indicating one-year survival of 45% in patients with chronic liver disease and cirrhosis.  This score is determined by the study of the following five factors: bilirubin, albumin, international normalized ratio, presence and degree of ascites, and presence and degree of encephalopathy.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"70947BE2-8C05-FDFA-E040-BB89AD433B54","latestVersionIndicator":"Yes","beginDate":"2009-08-07","endDate":null,"createdBy":"ALAIS","dateCreated":"2009-08-07","modifiedBy":"COOPERM","dateModified":"2018-08-22","changeDescription":"Concept annotation added for UPitt/TCGA.  Ylu, 02/26/2015.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"9D363884-9635-60FA-E053-F662850A0649","beginDate":"2019-12-27","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2020-01-28","modifiedBy":"ONEDATA","dateModified":"2020-01-28","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008556","version":"1","preferredName":"Assessment Results","preferredDefinition":"the results of evaluations of the patient and the patient's disease.","longName":"ASSESS_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2D08DE9-38BB-7208-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"7153839","version":"1","preferredName":"Child-Pugh Clinical Classification Category","preferredDefinition":"A standardized rating scale used to assess the severity of liver cirrhosis and determine the prognosis, the required strength of treatment, and the necessity of liver transplantation. This instrument uses the following clinical and lab criteria: encephalopathy grade, ascites, bilirubin, albumin, and prothrombin index.:A grouping of items based on some commonality or by user defined characteristics.","longName":"C121007:C25372","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Child-Pugh Clinical Classification","conceptCode":"C121007","definition":"A standardized rating scale used to assess the severity of liver cirrhosis and determine the prognosis, the required strength of treatment, and the necessity of liver transplantation. This instrument uses the following clinical and lab criteria: encephalopathy grade, ascites, bilirubin, albumin, and prothrombin index.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Category","conceptCode":"C25372","definition":"A grouping of items based on some commonality or by user defined characteristics.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9D33A65F-7B22-631B-E053-F662850AE025","latestVersionIndicator":"Yes","beginDate":"2020-01-28","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2020-01-28","modifiedBy":"ONEDATA","dateModified":"2020-01-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CPTAC: Clinical Proteomic Tumor Analysis Consortium","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"9AB26B74-F082-7194-E053-F662850A4802","latestVersionIndicator":"Yes","beginDate":"2019-12-27","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-12-27","modifiedBy":"KNABLEJ","dateModified":"2020-02-14","changeDescription":"2/14/20 jk Released per CPTAC SME (Linda) review and approval.  1/28/20 jk revised rep term and PVs to match CHOL CRF responses per Mathangi. 12/27/19 jk created for CPTAC LIHC and CHOL baseline CRFs.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"6601273","version":"1","longName":"CPTAC (Clinical Proteomic Tumor Analysis Consortium)","context":"OCCPR","ClassificationSchemeItems":[{"publicId":"6776762","version":"1","longName":"Bile duct and Liver","context":"OCCPR"},{"publicId":"6779538","version":"1","longName":"CHOL Baseline","context":"OCCPR"},{"publicId":"6779541","version":"1","longName":"LIHC Baseline","context":"OCCPR"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Child-Pugh Classification","type":"Preferred Question Text","description":"Child-Pugh Classification","url":null,"context":"OCCPR"}],"origin":"CPTAC: Clinical Proteomic Tumor Analysis Consortium","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"9D33F3BD-A7AE-18EA-E053-F662850ACE7C","latestVersionIndicator":"Yes","beginDate":"2020-01-28","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2020-01-28","modifiedBy":"KNABLEJ","dateModified":"2020-02-14","changeDescription":"2/14/20 jk Released per CPTAC SME (Linda) review and approval.  1/28/20 jk created for CPTAC LIHC and CHOL baseline CRFs.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}